CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $23.61M, above the global median of $18.73M
- FinancialsAltman Z-Score 3.25: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.28%Above 5Y avg (1.95%)
Annual Rate
CNY 0.90Paid annual
Payout Ratio
43.3%Sustainable
Payback Period
29.8 yr
Last Ex-Dividend
Apr 28, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.23BCNY631.78M · vs all stocks (USD)
Trailing P/E
12.71xRevenue (TTM)
3.18BCNY474.34M · vs all stocks (USD)
Profit Margin
9.96%Beta
0.0710xvs all stocks
52-Week Change
-32.76%vs all stocks
Market Capitalization
4.23BCNY631.78M · vs all stocks (USD)
Enterprise Value
2.92BCNY435.43M · vs all stocks (USD)
Trailing P/E
12.71xForward P/E
5.77xPrice to Sales (TTM)
1.28xPrice to Book (MRQ)
1.50xEnterprise to Revenue
0.9180xEnterprise to EBITDA
11.12xGross Margin
59.26%Profit Margin
9.96%Operating Margin
10.53%Return on Assets (TTM)
3.04%Return on Equity (TTM)
12.25%Revenue (TTM)
3.18BCNY474.34M · vs all stocks (USD)
Revenue per Share (TTM)
20.90CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-19.10%Gross Profit (TTM)
1.89BCNY282.93M · vs all stocks (USD)
EBITDA (TTM)
410.48MCNY61.30M · vs all stocks (USD)
Net Income (TTM)
316.43MCNY47.25M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-19.00%Operating Cash Flow (TTM)
339.29MCNY50.67M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
158.08MCNY23.61M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.9000CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
3.28%vs all stocks
5-Year Average Dividend Yield
1.95%vs all stocks
Payout Ratio
43.27%Minority Interest (Equity)
20.40MCNYFY2025 · Dec 31, 2025Revenue
3.37BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.40BCNYFY2025 · Dec 31, 2025Gross Profit
1.97BCNYFY2025 · Dec 31, 2025Operating Income
284.48MCNY42.48M · vs all stocks (USD)
Pre-tax Income
391.06MCNYFY2025 · Dec 31, 2025Income Tax Expense
25.84MCNYFY2025 · Dec 31, 2025Net Income
365.22MCNYFY2025 · Dec 31, 2025EBIT
404.25MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
449.94MCNYFY2025 · Dec 31, 2025Research & Development
98.68MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.33BCNYFY2025 · Dec 31, 2025Other Operating Expenses
26.76MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
325.05KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
13.19MCNYFY2025 · Dec 31, 2025EPS (Basic)
2.37CNYFY2025 · Dec 31, 2025EPS (Diluted)
2.37CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
151.83MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
151.83MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
365.22MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-5.38MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
370.71MCNYFY2025 · Dec 31, 2025Free Cash Flow
270.42MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
112.53MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
365.22MCNYFY2025 · Dec 31, 2025Other Non-cash Items
35.95MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-40.58MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
10.12MCNYFY2025 · Dec 31, 2025Capital Expenditures
-100.29MCNYFY2025 · Dec 31, 2025Purchase of Investments
-6.00MCNYFY2025 · Dec 31, 2025Sale of Investments
19.67MCNYFY2025 · Dec 31, 2025Other Investing Activity
-61.04MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-147.65MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
85.58MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-111.11MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-141.30MCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.38MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-168.20MCNYFY2025 · Dec 31, 2025Shares Outstanding
153.40MSharesUpdated Sep 22, 2026Float Shares
108.74MSharesUpdated Sep 22, 2026% Held by Insiders
34.49%vs all stocks
% Held by Institutions
4.16%vs all stocks
Total Cash (MRQ)
1.25BCNY187.03M · vs all stocks (USD)
Total Cash per Share (MRQ)
8.16CNYUpdated Sep 22, 2026Total Debt (MRQ)
94.25MCNY14.07M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0347xCurrent Ratio (MRQ)
1.65xBook Value per Share (MRQ)
17.57CNYUpdated Sep 22, 2026Total Assets
4.53BCNY676.00M · vs all stocks (USD)
Total Current Assets
2.75BCNYFY2025 · Dec 31, 2025Total Liabilities
1.85BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.78BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
114.27MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.74BCNYFY2025 · Dec 31, 2025Cash
110.24MCNYFY2025 · Dec 31, 2025Cash Equivalents
3.47MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
113.71MCNYFY2025 · Dec 31, 2025Other Short-term Investments
954.14MCNYFY2025 · Dec 31, 2025Accounts Receivable
780.81MCNYFY2025 · Dec 31, 2025Inventory
286.57MCNYFY2025 · Dec 31, 2025Accounts Payable
642.52MCNYFY2025 · Dec 31, 2025Short-term Debt
61.04MCNYFY2025 · Dec 31, 2025Other Current Liabilities
674.66MCNYFY2025 · Dec 31, 2025Long-term Debt
65.06MCNYFY2025 · Dec 31, 2025Common Stock (Book)
153.40MCNYFY2025 · Dec 31, 2025Retained Earnings
1.83BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.68BCNY399.73M · vs all stocks (USD)
52-Week Low
24.68CNYUpdated Sep 22, 202652-Week High
41.00CNYUpdated Sep 22, 202652-Week Change
-32.76%vs all stocks
Beta
0.0710xvs all stocks
50-Day MA
28.23CNYUpdated Sep 22, 2026200-Day MA
31.17CNYUpdated Sep 22, 2026Avg 10-Day Volume
1.22MSharesUpdated Sep 22, 2026Avg 30-Day Volume
2.17MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
2.08CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.25: safe zoneNotable
Altman Z-Score: 3.25
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $23.61M, above the global median of $18.73MNotable
Levered free cash flow (USD): 23,606,626.377Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Nanjing Vishee Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou Minsheng Healthcare Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai Sailun Biotech Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tianjin Lisheng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
ProKidney Corp
Tier 1ProductionApproval-Gated PipelineRule
Lionco Pharmaceutical Group Inc.
Tier 1ProductionApproval-Gated PipelineRule
Lanzhou Foci Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Aura Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Contec Medical Systems Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Guangdong Biolight Meditech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow